Hideaki Minoura Selected Research

Insulin (Novolin)

9/2013	Chronic treatment with novel GPR40 agonists improve whole-body glucose metabolism based on the glucose-dependent insulin secretion.
9/2005	Ameliorating effect of FK614, a novel nonthiazolidinedione peroxisome proliferator-activated receptor gamma agonist, on insulin resistance in Zucker fatty rat.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hideaki Minoura Research Topics

Disease

3	Type 2 Diabetes Mellitus (MODY) 01/2017 - 09/2013
3	Insulin Resistance 09/2013 - 06/2004
1	Body Weight (Weight, Body) 01/2017
1	Hyperglycemia 01/2017
1	Overweight 01/2017
1	Tyrosinemias (Tyrosinemia) 12/2015
1	Glucose Intolerance 09/2005
1	Hypertriglyceridemia 06/2004

Drug/Important Bio-Agent (IBA)

2	Glucose (Dextrose)FDA LinkGeneric 01/2017 - 09/2005
2	Insulin (Novolin)FDA Link 09/2013 - 09/2005
2	Rosiglitazone (Avandia)FDA Link 09/2005 - 06/2004
2	Pioglitazone (Actos)FDA Link 09/2005 - 06/2004
1	Sodium-Glucose Transport ProteinsIBA 01/2017
1	Hemoglobins (Hemoglobin)IBA 01/2017
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2017
1	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2017
1	ipragliflozinIBA 01/2017
1	nitisinone (Orfadin)FDA Link 12/2015
1	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2014
1	bis(2- ((4- ((4'- (2- hydroxyethoxy)- 2'- methyl(1,1'- biphenyl)- 3- yl)methoxy)phenyl)methyl)- 3,5- dioxo- 1,2,4- oxadiazolidine)IBA 09/2013
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 09/2005
1	PPAR-gamma AgonistsIBA 09/2005
1	PPAR gammaIBA 06/2004

Therapy/Procedure

1	Therapeutics 09/2013